Study Details

The observational primary progressive aphasia (PPA) research program at Northwestern University seeks to study individuals living with PPA over time using neuropsychological testing and advanced imaging techniques. Participants are asked to come to Chicago in order to help: better understand progression in PPA and its link to brain changes, increase awareness of PPA and better educate patients, families, and clinicians, and identify biomarkers that will lead to earlier diagnosis and earlier intervention. Participants are compensated for participation and travel expenses and meals are covered for those not local to Chicago. Eligibility CriteriaYou must carry a diagnosis of Primary Progressive Aphasia, established at a thorough evaluation prior to enrollment. If you think you may have dementia, but have not yet been evaluated, you must first undergo a clinical evaluation. This clinical evaluation is not part of the research. Patients must also meet screening criteria which require the patient to be a right-handed, native English speaker and safe to undergo a 3T MRI. Principal Investigator Mesulam, Marek-Marsel ClinicalTrials.gov IdentifierNCT00537004IRB number STU00026372 More Info Join our Registry Email Los, Michelle Anne Phone 312 908 9681

The observational primary progressive aphasia (PPA) research program at Northwestern University seeks to study individuals living with PPA over time using neuropsychological testing and advanced imaging techniques. Participants are asked to come to Chicago in order to help:

better understand progression in PPA and its link to brain changes,

increase awareness of PPA and better educate patients, families, and clinicians, and

identify biomarkers that will lead to earlier diagnosis and earlier intervention.

Participants are compensated for participation and travel expenses and meals are covered for those not local to Chicago.

Eligibility CriteriaYou must carry a diagnosis of Primary Progressive Aphasia, established at a thorough evaluation prior to enrollment. If you think you may have dementia, but have not yet been evaluated, you must first undergo a clinical evaluation. This clinical evaluation is not part of the research. Patients must also meet screening criteria which require the patient to be a right-handed, native English speaker and safe to undergo a 3T MRI.

Principal Investigator

Mesulam, Marek-Marsel

ClinicalTrials.gov IdentifierNCT00537004IRB number STU00026372

More Info

Join our Registry

Email Los, Michelle Anne Phone 312 908 9681